Prepare for your visit
Andrew V Doodnauth
Internal Medicine · Brooklyn, NY · NPI 1639630569
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$12,386.17
in general payments reported to CMS, 2019-2025 · $10K in 2025
The $10K reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Who reported paying
General payments only, top 6 by amount.
- Abbott Laboratories $4,798.90
- Medtronic, INC. $3,519.51
- Kestra Medical Technology Services, INC. $798.47
- Zoll Services LLC (A/K/A Zoll Lifecor Corp) $795.73
- Boston Scientific Corporation $606.17
- Scpharmaceuticals INC. $424.78
Drugs and devices associated with these payments
Assurity Tacticath Assure Wcd Lifevest Furoscix Optimizer Amvuttra General - Tachy Micra Xarelto Cardiomems Farapulse
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Andrew Doodnauth listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11395721/andrew-v-doodnauth